Compositions for conferring tolerance to viral disease in social insects, and the use thereof
Compositions and methods for reducing susceptibility to infectious disease in bees using RNA interference technology, and more particularly, prevention and treatment of viral infections in honeybees such as Israel acute paralysis virus (IAPV) by feeding of pathogen-specific dsRNA. Further, multiple-pathogen specific dsRNA is disclosed.
1. An isolated nucleic acid agent comprising an IAPV-specific double stranded ribonucleic acid (RNA) consisting of SEQ ID NO: 34 and an RNA sequence complementary to the entire SEQ ID NO: 34.
2. The isolated nucleic acid agent of claim 1 , further comprising a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 54-9532.
3. The isolated nucleic acid agent of claim 1 , further comprising a double stranded RNA comprising an RNA sequence complementary to the nucleic acid sequence of SEQ ID NOs: 24 or 33.
4. A nucleic acid construct comprising a nucleic acid sequence encoding the isolated nucleic acid agent of claim 1 .
5. A composition comprising bee feed and the nucleic acid agent of claim 1 .
6. The composition of claim 5 , wherein said composition is in solid form.
7. The composition of claim 5 , wherein said composition is in liquid form.
8. The composition of claim 7 , wherein said liquid is a sucrose solution.
9. The composition of claim 7 , wherein said liquid is a corn syrup solution.
10. The composition of claim 7 , wherein said liquid further comprises a carbohydrate or sugar supplement.
11. The composition of claim 5 , wherein said composition comprises protein.
12. The composition of claim 11 , wherein said protein is in the form of pollen and/or soy patties.
13. A method for reducing the susceptibility of a bee to a disease caused by Israel Acute Paralysis Virus (IAPV) comprising feeding the bee a composition consisting of bee feed and an effective amount of a nucleic acid agent comprising an IAPV-specific double stranded ribonucleic acid (RNA) consisting of SEQ ID NO: 34 and an RNA sequence complementary to the entire SEQ ID NO: 34, thereby reducing the susceptibility of said bee to a disease caused by IAPV.
14. The method of claim 13 , wherein said bee is a honeybee.
15. The method of claim 14 , wherein said honeybee is a forager.
16. The method of claim 14 , wherein said honeybee is a hive bee.
17. The method of claim 14 , wherein said honeybee is a bee of a colony, wherein said feeding reduces the susceptibility of said bee colony to said disease.
18. The method of claim 13 , wherein said disease is Colony Collapse Disorder.
19. The method of claim 13 , wherein said nucleic acid agent further comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 54-9532.
20. The method of claim 13 , wherein said nucleic acid agent further comprises a double stranded RNA comprising an RNA sequence complementary to the nucleic acid sequence of SEQ ID NOs: 24 or 33.
21. The method of claim 13 , wherein said feeding comprises providing a liquid bee-ingestible composition.
22. The methods of claim 13 , wherein said feeding comprises providing a solid bee-ingestible composition.
23. A method of reducing the susceptibility of honeybees to Colony Collapse Disorder (CCD), the method comprising feeding to the honeybee colony a bee-ingestible composition consisting of bee feed and an effective amount of a nucleic acid agent comprising an Israel Acute Paralysis Virus-specific double stranded ribonucleic nucleic acid (RNA) consisting of SEQ ID NO: 34 and an RNA sequence complementary to the entire SEQ ID NO: 34, thereby reducing the susceptibility of said honeybees to CCD.